Budesonide Inhaled Corticosteroid Pediatric Dosing
Inhaled corticosteroid dosing for asthma in children via nebulizer or MDI.
Age in years
NAEPP asthma severity classification
Device for administration
⚠️ Warnings & Contraindications
- Only ICS with FDA approval for children <4 years (nebulizer suspension)
- Monitor growth velocity; ICS may reduce growth by approximately 0.5-1 cm/year initially
- Use spacer with MDI; wash face after nebulizer use to prevent skin effects
- Rinse mouth after each use to prevent oral candidiasis
- Not for acute bronchospasm - use SABA for rescue
- Systemic effects possible at high doses
ℹ️ Clinical Notes
Nebulizer suspension: 0.25 mg/2mL, 0.5 mg/2mL. MDI: 90 mcg/puff (Pulmicort Flexhaler: 90 mcg/inhalation). Can be mixed with albuterol in same nebulizer.
References
- Budesonide (inhalation route) - Mayo Clinic - Mayo Clinic (2026)
- NAEPP Asthma Guidelines - Comparative ICS dosages - NHLBI (2007)
Medical Disclaimer
This calculator is provided for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read or calculated using this tool.
The authors and publishers of this calculator make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability, or availability of the information, products, services, or related graphics contained within this tool for any purpose.